DIRECTOR TRANSACTIONS

Insider Trades: Directors load up on shares in 11 ASX 200 companies

A summary of noteworthy ASX 200 director transactions between 6-14 March.

Lead Writer
14 March 2023
This article is more than 12 months old and may be outdated
2 min read
Insider Trades: Directors load up on shares in 11 ASX 200 companies

Source: iStock

Mentioned

KEY POINTS

  • Harvey Norman's Co-founder Gerry Harvey has purchased $20.7 million worth of shares so far in March
  • APM Human Services founder Megan Wynne makes the company's first director purchase since its November 2021 IPO
  • Bapcor directors have made 19 on-market trades since 2021

A summary of noteworthy S&P/ASX 200 director transactions between 6-14 March.

Top large cap insider buys

Code
Company
Date
Director
Type
Price
Value
Notes
Harvey Norman
7/03/2023
Gerald Harvey
Buy
$3.85
$4,193,012
On-market trade
Harvey Norman
6/03/2023
Gerald Harvey
Buy
$3.82
$3,592,116
On-market trade
Harvey Norman
8/03/2023
Gerald Harvey
Buy
$3.85
$2,502,565
On-market trade
Harvey Norman
9/03/2023
Gerald Harvey
Buy
$3.86
$2,393,944
On-market trade
APM Human Services
3/03/2023
Megan Wynne
Buy
$2.35
$1,985,224
On-market trade
Bapcor
7/03/2023
Mark Bernhard
Buy
$6.630
$66,300
On-market trade
Breville Group
10/03/2023
Lawrence Myers
Buy
$19.26
$577,785
On-market trade
Whitehaven Coal
8/03/2023
Wallis Graham
Buy
$7.13
$85,600
On-market trade
ASX
6/03/2023
Heather Smith
Buy
$67.34
$67,343
On-market trade
Bapcor
3/03/2023
Kathryn Spargo
Buy
$6.48
$64,750
On-market trade
Baby Bunting
3/03/2023
Gary Levin
Buy
$2.02
$60,600
On-market trade
G8 Education
6/03/2023
Peter Trimble
Buy
$1.22
$30,500
On-market trade
Regis Resources
6/03/2023
Paul Arndt
Buy
$1.74
$29,962
On-market trade
Cochlear
6/03/2023
Michael del Prado
Buy
$150.58
$19,877
On-market trade
Allkem
6/03/2023
Florencia Heredia
Buy
$8.52
$19,849
On-market trade

Interesting observations

Harvey Norman: Mr Harvey walks the walk

In March alone, co-founder and executive chairman of Harvey Norman, Gerry Harvey purchased six parcels worth a collective $20.7 million.

Harvey has strongly defended the company's half-year results, arguing that the retailer has the balance sheet strength to withstand economic headwinds. The interim result said otherwise, with first-half profits down 15.1% and January 2023 sales for Australian franchisees falling 10.2% against the prior period.

From a broker perspective, Goldman Sachs retained a BUY rating for the stock with a $4.70 target price. Some key takeaways from the note include:

  • 2H23 sales are expected to continue to decline, while "tactical support and higher promotions will further pressure EBIT margins."

  • Despite a disappointing 1H23, a Buy rating was retained due to high property valuations (~$3.3 per share at average book value or 70% of the company's market cap)

  • Harvey Norman trades at approximately 6x FY24 price-to-earnings vs. JB Hi-Fi which trades at 14.5x

APM Human Services: Another founder purchase

APM listed in November 2021 at an offer price of $3.55 per share. During this time, executive chair and founder Megan Wynne was also instructed to sell approximately $71.3 million shares at the offer price.

Wynn's almost $2 million purchase represents the company's first director buy since November 2021.

On Monday, APM shares hit an all-time low of $2.13, down 40% from its offer price. The $2 million stake is down around 7% from her entry price.

Bapcor: Lots of buying

Bapcor's directors have been accumulating shares in mostly $20,000 to $80,000 blocks for more than two years.

Since 2021, there's been 19 on-market trades by various directors worth a collective $1.13 million at a weighted average price of $6.86.

That's approximately 7.6% below Bapcor's current share price of $6.40 (but the stock has also paid out 52 cents worth of dividends since 2021).

ABOUT THE AUTHOR

Lead Writer

Kerry holds a Bachelor of Commerce from Monash University. He is passionate about equity research and trading (swing and intraday), with a focus on breaking down market-related catalysts into clear, contextual insights and developing data-driven market biases.

05/06/2026